Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3025]
News [6109]
Articles [120]
Editorials [18]
Conferences [179]
elearning [32]
Novel ADC for relapsed/refractory lymphoma
Dr Laurie Sehn - BC Cancer Agency, Vancouver, Canada
Novel ADC for relapsed/refractory lymphoma ( Dr Laurie Sehn - BC Cancer Agency, Vancouver, Canada )
16 Jun 2018
iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia
Dr Meletios Dimopoulos - National and Kapodistrian University of Athens School...
iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia ( Dr Meletios Dimopoulos - National and Kapodistrian University of Athens School of Medicine, Athens, Greece )
16 Jun 2018
Updated results from a phase I trial of CAR-T cell therapy for r/rMM
Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
Updated results from a phase I trial of CAR-T cell therapy for r/rMM ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )
15 Jun 2018
Emerging post-transplant therapeutic options for relapsed Hodgkin lymphoma
Dr Astrid Pavlovsky - Center for Haematology, Buenos Aires, Argentina
Emerging post-transplant therapeutic options for relapsed Hodgkin lymphoma ( Dr Astrid Pavlovsky - Center for Haematology, Buenos Aires, Argentina )
15 Jun 2018
Updates from Myeloma XI trial
Dr Charlotte Pawlyn - The Institute of Cancer Research, London, UK
Updates from Myeloma XI trial ( Dr Charlotte Pawlyn - The Institute of Cancer Research, London, UK )
15 Jun 2018
Ribosomal lesions promote oncogenic mutagenesis
Dr Sergey Sulima - Katholieke Universiteit Leuven, Lueven, Belgium
Ribosomal lesions promote oncogenic mutagenesis ( Dr Sergey Sulima - Katholieke Universiteit Leuven, Lueven, Belgium )
15 Jun 2018
Updated data from the FORTE trial of carfilzomib plus lenalidomide or...
Dr Francesca Gay - University of Torino, Torino, Italy
Updated data from the FORTE trial of carfilzomib plus lenalidomide or cyclophosphamide for myeloma ( Dr Francesca Gay - University of Torino, Torino, Italy )
15 Jun 2018
Improved OS with obinutuzumab in the CLL11 study
Dr Valentin Goede - St. Marien-Hospital, Cologne, Germany
Improved OS with obinutuzumab in the CLL11 study ( Dr Valentin Goede - St. Marien-Hospital, Cologne, Germany )
15 Jun 2018
Disease control in advanced Hodgkin lymphoma
Dr Olivier Casasnovas - CHU de Dijon, Dijon, France
Disease control in advanced Hodgkin lymphoma ( Dr Olivier Casasnovas - CHU de Dijon, Dijon, France )
15 Jun 2018
Interim results of RELEVANCE trial in follicular lymphoma
Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France
Interim results of RELEVANCE trial in follicular lymphoma ( Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France )
15 Jun 2018
Update on bb2121 for relapsed myeloma
Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
Update on bb2121 for relapsed myeloma ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )
15 Jun 2018
Mapping 3D genome dynamics in B cells
Dr José Ignacio Martin-Subero - University of Barcelona, Barcelona, Spain
Mapping 3D genome dynamics in B cells ( Dr José Ignacio Martin-Subero - University of Barcelona, Barcelona, Spain )
15 Jun 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation